Skip Nav Destination
OnlineFirst
Research Article May 10 2022
An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors
Jitka Fucikova; Michal Hensler; Lenka Kasikova; Tereza Lanickova; Josef Pasulka; Jana Rakova; Jana Drozenova; Tessa Fredriksen; Marek Hraska; Tereza Hrnciarova; Klara Sochorova; Daniela Rozkova; Ludek Sojka; Pavel Dundr; Jan Laco; Tomas Brtnicky; Ivan Praznovec; Michael J. Halaska; Lukas Rob; Ales Ryska; An Coosemans; Ignace Vergote; David Cibula; Jirina Bartunkova; Jerome Galon; Lorenzo Galluzzi; Radek Spisek
Clin Cancer Res clincanres.4413.2021.
Research Article May 9 2022
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer
Christopher J. Sweeney; Ivor J. Percent; Sunil Babu; Jennifer L. Cultrera; Bryan A. Mehlhaff; Oscar B. Goodman; David S. Morris; Ian D. Schnadig; Costantine Albany; Neal D. Shore; Paul R. Sieber; Susan C. Guba; Wei Zhang; Volker Wacheck; Gregory P. Donoho; Anna M. Szpurka; Sophie Callies; Boris Kin Lin; Johanna C. Bendell
Clin Cancer Res (2022)
Review Article May 9 2022
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
Simone C. Kleinendorst; Egbert Oosterwijk; Johan Bussink; Harm Westdorp; Mark W. Konijnenberg; Sandra Heskamp
Clin Cancer Res (2022)
Research Article May 6 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma
Beryl Manning-Geist; Sushmita Gordhandas; Ying L. Liu; Qin Zhou; Alexia Iasonos; Arnaud Da Cruz Paula; Diana Mandelker; Kara Long Roche; Oliver Zivanovic; Anna Maio; Yelena Kemel; Dennis S. Chi; Roisin E. O'Cearbhaill; Carol Aghajanian; Britta Weigelt; M. Herman Chui; Rachel N. Grisham
Clin Cancer Res (2022)
Review Article May 6 2022
The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents
Clin Cancer Res (2022)
Research Article May 6 2022
Shall We Dance: Evolving Partnerships of Targeted Therapies for AML
Clin Cancer Res (2022)
Research Article May 4 2022
A Randomized Ph2 Study of MEDI0680 in Combination With Durvalumab vs. Nivolumab Monotherapy in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Martin H. Voss; Arun A. Azad; Aaron R. Hansen; Jhanelle E. Gray; Sarah J. Welsh; Xuyang Song; Michael Kuziora; Lina Meinecke; Jorge Blando; Ikbel Achour; Yi Wang; Farzana Walcott; Sjoukje F. Oosting
Clin Cancer Res clincanres.4115.2021.
Research Article May 3 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Smita Sihag; Samuel C. Nussenzweig; Henry S. Walch; Meier Hsu; Kay See Tan; Sergio De La Torre; Yelena Y. Janjigian; Steven B. Maron; Geoffrey Y. Ku; Laura H. Tang; Pari M. Shah; Abraham Wu; David R. Jones; David B. Solit; Nikolaus Schultz; Karuna Ganesh; Michael F. Berger; Daniela Molena
Clin Cancer Res (2022)
Research Article May 3 2022
Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas
Alyxzandria M. Gaydosik; Connor J. Stonesifer; Alexandra E. Khaleel; Larisa J. Geskin; Patrizia Fuschiotti
Clin Cancer Res (2022)
Research Article May 3 2022
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Jun Wang; Thomas Kunzke; Verena M. Prade; Jian Shen; Achim Buck; Annette Feuchtinger; Ivonne Haffner; Birgit Luber; Drolaiz H.W. Liu; Rupert Langer; Florian Lordick; Na Sun; Axel Walch
Clin Cancer Res (2022)
Research Article May 3 2022
Report of the First International Symposium on NUT Carcinoma
Christopher A. French; Michael L. Cheng; Glenn J. Hanna; Steven G. DuBois; Nicole G. Chau; Christine L. Hann; Simone Storck; Ravi Salgia; Matteo Trucco; Jennifer Tseng; Anastasios Stathis; Richard Piekarz; Ulrich M. Lauer; Christophe Massard; Kelly Bennett; Shodeinde Coker; Ulrike Tontsch-Grunt; Martin L. Sos; Sida Liao; Catherine J. Wu; Kornelia Polyak; Sarina A. Piha-Paul; Geoffrey I. Shapiro
Clin Cancer Res (2022)
Research Article May 3 2022
What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet
Clin Cancer Res (2022)
Research Article April 29 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Nina Kim; Kelly J. Norsworthy; Sriram Subramaniam; Haiyan Chen; Michael L. Manning; Eliford Kitabi; Justin Earp; Lori A. Ehrlich; Olanrewaju O. Okusanya; Jonathon Vallejo; Brenda J. Gehrke; R. Angelo de Claro; Richard Pazdur
Clin Cancer Res (2022)
Research Article April 29 2022
Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102
Caitlyn B. Brashears; Bethany C. Prudner; Richa Rathore; Katharine E. Caldwell; Carina A. Dehner; Jane L. Buchanan; Sara E.S. Lange; Neal Poulin; Jennifer K. Sehn; Jason Roszik; Dirk Spitzer; Kevin B. Jones; Regis O'Keefe; Torsten O. Nielsen; Eric B. Taylor; Jason M. Held; William Hawkins; Brian A. Van Tine
Clin Cancer Res (2022)
Research Article April 29 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Andrew X. Zhu; Farshid Dayyani; Chia-Jui Yen; Zhenggang Ren; Yuxian Bai; Zhiqiang Meng; Hongming Pan; Paul Dillon; Shivani K. Mhatre; Vincent E. Gaillard; Sairy Hernandez; Robin Kate Kelley; Bruno Sangro
Clin Cancer Res (2022)
Research Article April 29 2022
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Gontran Verset; Ivan Borbath; Mark Karwal; Chris Verslype; Hans Van Vlierberghe; Adel Kardosh; Vittorina Zagonel; Per Stal; Debashis Sarker; Daniel H. Palmer; Arndt Vogel; Julien Edeline; Stephane Cattan; Masatoshi Kudo; Ann-Lii Cheng; Sadahisa Ogasawara; Bruno Daniele; Stephen L. Chan; Jennifer J. Knox; Shukui Qin; Abby B. Siegel; Michael Chisamore; Ken Hatogai; Anran Wang; Richard S. Finn; Andrew X. Zhu
Clin Cancer Res (2022)
Research Article April 29 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Lakshmi Nayak; Nathan Standifer; Jorg Dietrich; Jennifer L. Clarke; Gavin P. Dunn; Michael Lim; Timothy Cloughesy; Hui K. Gan; Elizabeth Flagg; Elizabeth George; Sarah Gaffey; Julia Hayden; Christina Holcroft; Patrick Y. Wen; Mary Macri; Andrew J. Park; Toni Ricciardi; Aileen Ryan; Paul Schwarzenberger; Ralph Venhaus; Melissa de los Reyes; Nicholas M. Durham; Todd Creasy; Raymond Y. Huang; Thomas Kaley; David A. Reardon
Clin Cancer Res (2022)
Research Article April 29 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Kim R.M. Blenman; Michal Marczyk; Thomas Karn; Tao Qing; Xiaotong Li; Vignesh Gunasekharan; Vesal Yaghoobi; Yalai Bai; Eiman Y. Ibrahim; Tristen Park; Andrea Silber; Denise M. Wolf; Emily Reisenbichler; Carsten Denkert; Bruno V. Sinn; Mariya Rozenblit; Julia Foldi; David L. Rimm; Sibylle Loibl; Lajos Pusztai
Clin Cancer Res (2022)
Research Article April 29 2022
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Wai-Tong Ng; Cheuk-Wai Choi; Barton But; Roger K.C. Ngan; Stewart Tung; Ashley C. Cheng; Dora L.W. Kwong; Tai-Xiang Lu; Anthony T.C. Chan; Harry Yiu; Sarah Lee; Frank Wong; Kam-Tong Yuen; Richard J. Chappell; Anne W.M. Lee
Clin Cancer Res (2022)
Research Article April 29 2022
Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs
Carla Rohrer Bley; Friederike Wolf; Patrik Gonçalves Jorge; Veljko Grilj; Ioannis Petridis; Benoit Petit; Till T. Böhlen; Raphael Moeckli; Charles Limoli; Jean Bourhis; Valeria Meier; Marie-Catherine Vozenin
Clin Cancer Res (2022)
Research Article April 29 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Markus W. Löffler; Stefania Gori; Francesco Izzo; Andrea Mayer-Mokler; Paolo A. Ascierto; Alfred Königsrainer; Yuk Ting Ma; Bruno Sangro; Sven Francque; Luisa Vonghia; Alessandro Inno; Antonio Avallone; Jörg Ludwig; Diego Duarte Alcoba; Christian Flohr; Katrin Aslan; Regina Mendrzyk; Heiko Schuster; Marco Borrelli; Danila Valmori; Tanguy Chaumette; Regina Heidenreich; Cécile Gouttefangeas; Greta Forlani; Maria Tagliamonte; Caterina Fusco; Roberta Penta; Mercedes Iñarrairaegui; Ulrike Gnad-Vogt; Carsten Reinhardt; Toni Weinschenk; Roberto S. Accolla; Harpreet Singh-Jasuja; Hans-Georg Rammensee; Luigi Buonaguro
Clin Cancer Res (2022)
Research Article April 29 2022
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma
Clin Cancer Res (2022)
Research Article April 25 2022
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Satoshi Fujii; Daisuke Kotani; Masahiro Hattori; Masato Nishihara; Toshihide Shikanai; Junji Hashimoto; Yuki Hama; Takuya Nishino; Mizuto Suzuki; Ayatoshi Yoshidumi; Makoto Ueno; Yoshito Komatsu; Toshiki Masuishi; Hiroki Hara; Taito Esaki; Yoshiaki Nakamura; Hideaki Bando; Tomoyuki Yamada; Takayuki Yoshino
Clin Cancer Res (2022)
Research Article April 25 2022
Targeting Podoplanin for the Treatment of Osteosarcoma
Ai Takemoto; Satoshi Takagi; Takao Ukaji; Nobuhiko Gyobu; Mamoru Kakino; Miho Takami; Asami Kobayashi; Marie Lebel; Tokuichi Kawaguchi; Minoru Sugawara; Kazue Tsuji-Takayama; Kenji Ichihara; Yuki Funauchi; Keisuke Ae; Seiichi Matsumoto; Yoshiya Sugiura; Kengo Takeuchi; Tetsuo Noda; Ryohei Katayama; Naoya Fujita
Clin Cancer Res (2022)
Review Article April 25 2022
Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally
Clin Cancer Res (2022)
Research Article April 25 2022
Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNA
Clin Cancer Res (2022)
Research Article April 21 2022
Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Clare Vesely; Yien Ning Sophia Wong; Alexa Childs; Ayse U. Akarca; Pawan Dhami; Heli Vaikkinen; Lucia Conde; Javier Herrero; Olagunju Ogunbiyi; Amir Gander; Tu Vinh Luong; Chrissie Thirlwell; Martyn Caplin; Christos Toumpanakis; Karl Peggs; Sergio A. Quezada; Teresa Marafioti; Tim Meyer
Clin Cancer Res (2022)
Research Article April 21 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L. Bychkovsky; Tianyu Li; Jilliane Sotelo; Nabihah Tayob; Joanna Mercado; Israel Gomy; Anu Chittenden; Sarah Kane; Samantha Stokes; Melissa E. Hughes; Ji Seok Kim; Renato Umeton; Mark M. Awad; Panagiotis A. Konstantinopoulos; Matthew B. Yurgelun; Brian M. Wolpin; Mary-Ellen Taplin; Randall E. Newmark; Bruce E. Johnson; Neal I. Lindeman; Laura E. MacConaill; Judy E. Garber; Nancy U. Lin
Clin Cancer Res (2022)
Research Article April 21 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Christine H. Chung; Jiannong Li; Conor E. Steuer; Priyanka Bhateja; Matthew Johnson; Jude Masannat; Maria I. Poole; Feifei Song; Juan C. Hernandez-Prera; Helen Molina; Bruce M. Wenig; Sunil Kumar; Charlotte Kuperwasser; Philip J. Stephens; Joaquim M. Farinhas; Dong M. Shin; Julie A. Kish; Jameel Muzaffar; Kedar Kirtane; James W. Rocco; Michael J. Schell; Nabil F. Saba; Marcelo Bonomi
Clin Cancer Res (2022)
Research Article April 21 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
Martin Schuler; Lisa Zimmer; Kevin B. Kim; Jeffrey A. Sosman; Paolo A. Ascierto; Michael A. Postow; Filip Y.F.L. De Vos; Carla M.L. van Herpen; Matteo S. Carlino; Douglas B. Johnson; Carola Berking; Micaela B. Reddy; Allison S. Harney; Jordan D. Berlin; Rodabe N. Amaria
Clin Cancer Res (2022)
Research Article April 21 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
Michael J. Wagner; Yuzheng Zhang; Lee D. Cranmer; Elizabeth T. Loggers; Graeme Black; Sabrina McDonnell; Shannon Maxwell; Rylee Johnson; Roxanne Moore; Pedro Hermida de Viveiros; Lauri Aicher; Kimberly S. Smythe; Qianchuan He; Robin L. Jones; Seth M. Pollack
Clin Cancer Res (2022)
Research Article April 21 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC
Pedro Rocha; Jiexin Zhang; Raquel Laza-Briviesca; Alberto Cruz-Bermúdez; Neus Bota-Rabassedas; Beatriz Sanchez-Espiridon; Katsuhiro Yoshimura; Carmen Behrens; Wei Lu; Ximing Tang; Apar Pataer; Edwin R. Parra; Cara Haymaker; Junya Fujimoto; Stephen G. Swisher; John V. Heymach; Don L Gibbons; J. Jack Lee; Boris Sepesi; Tina Cascone; Luisa M. Solis; Mariano Provencio; Ignacio I. Wistuba; Humam Kadara
Clin Cancer Res (2022)
Research Article April 21 2022
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A. Philip; Ibrahim Azar; Joanne Xiu; Michael J. Hall; Andrew Eugene Hendifar; Emil Lou; Jimmy J. Hwang; Jun Gong; Rebecca Feldman; Michelle Ellis; Phil Stafford; David Spetzler; Moh'd M. Khushman; Davendra Sohal; A. Craig Lockhart; Benjamin A. Weinberg; Wafik S. El-Deiry; John Marshall; Anthony F. Shields; W. Michael Korn
Clin Cancer Res (2022)
Research Article April 21 2022
An Ascendant Challenge: Central Nervous System Metastases in ALK+ Lung Cancers
Clin Cancer Res (2022)
Research Article April 18 2022
VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Vinton W.T. Cheng; Nicholas de Pennington; Rasheed Zakaria; James R. Larkin; Sébastien Serres; Manjima Sarkar; Matthew A. Kirkman; Claire Bristow; Paula Croal; Puneet Plaha; Leticia Campo; Michael A. Chappell; Simon Lord; Michael D. Jenkinson; Mark R. Middleton; Nicola R. Sibson
Clin Cancer Res (2022)
Research Article April 14 2022
Predicting the Future: Machine-Based Learning for MRD Prognostication
Clin Cancer Res (2022)
Research Article April 14 2022
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells
Giulia Corradi; Barbara Bassani; Giorgia Simonetti; Sabina Sangaletti; Jayakumar Vadakekolathu; Maria Chiara Fontana; Martina Pazzaglia; Alessandro Gulino; Claudio Tripodo; Gianluca Cristiano; Lorenza Bandini; Emanuela Ottaviani; Darina Ocadlikova; Milena Piccioli; Giovanni Martinelli; Mario Paolo Colombo; Sergio Rutella; Michele Cavo; Marilena Ciciarello; Antonio Curti
Clin Cancer Res (2022)
Brief Report April 14 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy
Sunyoung Lee; Rachna T. Shroff; Shalini Makawita; Lianchun Xiao; Anaemy Danner De Armas; Priya Bhosale; Kavitha Reddy; Ahmed Shalaby; Kanwal Raghav; Shubham Pant; Robert A. Wolff; Milind Javle
Clin Cancer Res (2022)
Research Article April 14 2022
Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth
Krishna Madhavan; Ilango Balakrishnan; Senthilnath Lakshmanachetty; Angela Pierce; Bridget Sanford; Susan Fosmire; Hanan B. Elajaili; Faye Walker; Dong Wang; Eva S. Nozik; Siddhartha S. Mitra; Nathan A. Dahl; Rajeev Vibhakar; Sujatha Venkataraman
Clin Cancer Res (2022)
Research Article April 14 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
Matthew L. Hemming; Patrick Bhola; Michael A. Loycano; Justin A. Anderson; Madeleine L. Taddei; Leona A. Doyle; Elizaveta Lavrova; Jessica L. Andersen; Kelly S. Klega; Morgan R. Benson; Brian D. Crompton; Chandrajit P. Raut; Suzanne George; Anthony Letai; George D. Demetri; Ewa Sicinska
Clin Cancer Res (2022)
Research Article April 14 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
Toni T. Seppälä; Jacquelyn W. Zimmerman; Reecha Suri; Haley Zlomke; Gabriel D. Ivey; Annamaria Szabolcs; Christopher R. Shubert; John L. Cameron; William R. Burns; Kelly J. Lafaro; Jin He; Christopher L. Wolfgang; Ying S. Zou; Lei Zheng; David A. Tuveson; James R. Eshlemann; David P. Ryan; Alec C. Kimmelman; Theodore S. Hong; David T. Ting; Elizabeth M. Jaffee; Richard A. Burkhart
Clin Cancer Res (2022)
Research Article April 14 2022
First Clinical Results of Fluorescence Lifetime-Enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes
Rahul Pal; Marisa E. Hom; Nynke S. van den Berg; Thinzar M. Lwin; Yu-Jin Lee; Andrey Prilutskiy; William Faquin; Eric Yang; Srinivas V. Saladi; Mark A. Varvares; Eben L. Rosenthal; Anand T.N. Kumar
Clin Cancer Res (2022)
Research Article April 14 2022
PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials
Clin Cancer Res (2022)
Research Article April 14 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Joline S.J. Lim; Andrea L.A. Wong; Samuel G.W. Ow; Natalie Y.L. Ngoi; Gloria H.J. Chan; Yvonne L.E. Ang; Wan Qin Chong; Siew Eng Lim; Yi Wan Lim; Matilda Lee; Joan R.E. Choo; Hon Lyn Tan; Wei Peng Yong; Ross A. Soo; David S.P. Tan; Cheng Ean Chee; Raghav Sundar; Kritika Yadav; Supriya Jain; Lingzhi Wang; Bee Choo Tai; Boon Cher Goh; Soo-Chin Lee
Clin Cancer Res (2022)
Research Article April 12 2022
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
Hiroto Inaba; Jolieke G. van Oosterwijk; John C. Panetta; Lie Li; Daelynn R. Buelow; James S. Blachly; Sheila Shurtleff; Ching-Hon Pui; Raul C. Ribeiro; Jeffrey E. Rubnitz; Stanley Pounds; Sharyn D. Baker
Clin Cancer Res (2022)
Research Article April 12 2022
Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
Josep M. Llovet; Amit G. Singal; Augusto Villanueva; Richard S. Finn; Masatoshi Kudo; Peter R. Galle; Masafumi Ikeda; Sophie Callies; Louise M. McGrath; Chunxiao Wang; Paolo Abada; Ryan C. Widau; Elena Gonzalez-Gugel; Andrew X. Zhu
Clin Cancer Res (2022)
Research Article April 12 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial
Kaspar Draaisma; C. Mircea S. Tesileanu; Iris de Heer; Martin Klein; Marion Smits; Jaap C. Reijneveld; Paul M. Clement; Filip Y.F. de Vos; Antje Wick; Paul J. Mulholland; Martin J.B. Taphoorn; Michael Weller; Olivier L. Chinot; Johan M. Kros; Tina Verschuere; Corneel Coens; Vassilis Golfinopoulos; Thierry Gorlia; Ahmed Idbaih; Pierre A. Robe; Martin J. van den Bent; Pim J. French
Clin Cancer Res (2022)
Advertisement
